4.7 Article

Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2+ accumulation

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer

Erva Ozkan et al.

Summary: Ferroptosis, a novel cell death mechanism, shows potential therapeutic benefits in overcoming drug resistance in cancer. Cancer cells, which consume more iron, are particularly sensitive to ferroptosis, making it an excellent alternative for cell death induction and reversing drug resistance.

CURRENT MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Therapeutic strategies to overcome cisplatin resistance in ovarian cancer

Mengdi Song et al.

Summary: This review discusses the chemotherapeutic drugs and phytochemicals developed to overcome cisplatin-resistance ovarian cancer (CROC), highlighting the significance of combination therapy and the use of a nanoparticle delivery system in reversing cisplatin resistance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR

Fangfang Wang et al.

Summary: The study identifies shikonin as an inhibitor that suppresses DNA damage response (DDR) activated by chemotherapeutic drugs in cancer cells. It inhibits DDR signal activation through the degradation of ATM and ATR-interacting protein (ATRIP), the upstream regulators of DDR. These findings reveal shikonin as a pan DDR inhibitor and identify ATM as a primary factor in determining the chemo sensitizing effect of shikonin.

ACTA PHARMACEUTICA SINICA B (2022)

Article Biochemistry & Molecular Biology

All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis

Yanting Sun et al.

Summary: All-trans retinoic acid (ATRA) has been found to play a crucial role in ferroptosis in hepatocellular carcinoma (HCC), exerting anti-HCC effect by altering gene expression and regulating mitochondrial structure.

GENES & DISEASES (2022)

Article Biochemistry & Molecular Biology

Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutatnt colorectal cancer

Hao Chen et al.

Summary: The combination of aspirin and a ferroptosis inducer enhances cytotoxicity in cancer cells with PIK3CA mutations, showing promising therapeutic effects.

REDOX BIOLOGY (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Cell Biology

The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival

Shih-Kai Chiang et al.

Summary: HO-1 plays a significant role in oxidative stress and tumorigenesis, regulating key signaling pathways in the progression of cancer. While the relationship between HO-1 and cancer development has not been thoroughly examined, it holds great potential in advancing research in this area.

CELLS (2021)

Review Biochemistry & Molecular Biology

Regulation of the Expression of Heme Oxygenase-1: Signal Transduction, Gene Promoter Activation, and Beyond

Maria Victoria Medina et al.

ANTIOXIDANTS & REDOX SIGNALING (2020)

Article Biochemistry & Molecular Biology

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition

Renxin Yi et al.

BIOSCIENCE REPORTS (2020)

Review Cell Biology

Iron Metabolism in Ferroptosis

Xin Chen et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

Ovarian Cancer: An Integrated Review

Christine Stewart et al.

SEMINARS IN ONCOLOGY NURSING (2019)

Review Oncology

Targeting Ferroptosis to Iron Out Cancer

Behrouz Hassannia et al.

CANCER CELL (2019)

Review Biochemistry & Molecular Biology

Cisplatin: The first metal based anticancer drug

Sumit Ghosh

BIOORGANIC CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Pharmacological properties and derivatives of shikonin-A review in recent years

Chuanjie Guo et al.

PHARMACOLOGICAL RESEARCH (2019)

Review Biochemistry & Molecular Biology

A Dual Role of Heme Oxygenase-1 in Cancer Cells

Shih-Kai Chiang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis

Ling-Chu Chang et al.

CANCER LETTERS (2018)

Review Cell Biology

Ferrootosis: Death by Lipid Peroxidation

Wan Seok Yang et al.

TRENDS IN CELL BIOLOGY (2016)

Article Oncology

Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death

Min-Young Kwon et al.

ONCOTARGET (2015)

Article Biochemistry & Molecular Biology

Regulation of Ferroptotic Cancer Cell Death by GPX4

Wan Seok Yang et al.

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.